<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04229316</url>
  </required_header>
  <id_info>
    <org_study_id>DMS-3343</org_study_id>
    <nct_id>NCT04229316</nct_id>
  </id_info>
  <brief_title>Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study</brief_title>
  <official_title>Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZygoFix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ZygoFix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ZygoFix has developed a system consisting of zLOCK Facet Fusion System. The zLOCK Facet&#xD;
      Fusion System is intended for single level stabilization of a spinal motion segment to&#xD;
      promote bonny fusion of the joint. The system is designed for percutaneous deployment. The&#xD;
      zLOCK implant is designed to be deployed in the facet joint thereby utilizing the body's&#xD;
      natural mechanical structure without adding an external scaffold (see figure below).&#xD;
&#xD;
      The zLOCK implant is inserted into the facet joint space while it adapts to the joint's&#xD;
      changing geometry. Stabilization is achieved by firm grip of each joint bone and resisting to&#xD;
      any relative motion. The zLOCK implant is placed percutaneously and requires only one&#xD;
      incision per side, thereby reducing the invasiveness, procedure duration and shorten the&#xD;
      recovery period.&#xD;
&#xD;
      This pilot study was designed in order to assess the safety and effectiveness of the zLOCK&#xD;
      system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety assessment - no device related reoperation</measure>
    <time_frame>3 months</time_frame>
    <description>The safety of the zLOCK Facet Implant System will be established based on the absence of device related reoperations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy assessment - achieving facet fusion 12 months post procedure</measure>
    <time_frame>12 months</time_frame>
    <description>The efficacy of using the zLOCK System will be determined by achieving facet fusion 12 months post procedure.&#xD;
Patient is defined &quot;success&quot; if facet fusion is achieved at 12 months post procedure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>zLock Facet Locking Implant System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>zLOCK Facet Stabilization System</intervention_name>
    <description>zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains</description>
    <arm_group_label>zLock Facet Locking Implant System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is scheduled for spine surgery with at least one of the following:&#xD;
&#xD;
             When used in adjunct to an intervertebral front cage:&#xD;
&#xD;
               -  Degenerative Spondylolisthesis up to grade 2&#xD;
&#xD;
               -  Mild to Moderate Degenerative disc disease (DDD)&#xD;
&#xD;
               -  Degeneration of the facets - following validating the pain source by facet&#xD;
                  injection.&#xD;
&#xD;
             When used stand-alone:&#xD;
&#xD;
               -  Degenerative Spondylolisthesis grade 1-2&#xD;
&#xD;
               -  Moderate to severe Stenosis with listhesis&#xD;
&#xD;
               -  Moderate to severe stenosis without listhesis (in cases that the investigator&#xD;
                  determines stabilization is required).&#xD;
&#xD;
               -  Degeneration of the facets- following validating the pain source by facet&#xD;
                  injection.&#xD;
&#xD;
          2. Claudication due to moderate to severe stenosis (central/ foraminal) as verified by&#xD;
             imaging.&#xD;
&#xD;
          3. 18&lt; Age &lt; 75&#xD;
&#xD;
          4. Weight &lt; 100Kg&#xD;
&#xD;
          5. Signed informed consent form&#xD;
&#xD;
          6. At least 3 months of unsuccessful conventional treatments&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Fusion procedure performed or required in more than one inter-vertebrae space.&#xD;
&#xD;
          2. Active systemic infection or infection localized to the site of the proposed&#xD;
             implantation are contraindications to implantation.&#xD;
&#xD;
          3. Osteoporosis&#xD;
&#xD;
          4. Absence of posterior spinal elements including the pedicle, pars interarticularis,&#xD;
             facet joints, spinous process and the majority of the lamina which make it unstable or&#xD;
             not possible to place.&#xD;
&#xD;
          5. Any entity or conditions that totally preclude the possibility of fusion, i.e.,&#xD;
             cancer, kidney dialysis, or osteopenia, are relative contraindications.&#xD;
&#xD;
          6. Obesity (BMI â‰¥30)&#xD;
&#xD;
          7. Foreign body sensitivity&#xD;
&#xD;
          8. Alcoholism, or drug abuse&#xD;
&#xD;
          9. Subject with a cardiac pacemaker or other implanted electro medical device&#xD;
&#xD;
         10. Subject with known condition of drug abuse and/or alcoholism&#xD;
&#xD;
         11. Women who are either pregnant or nursing at the time of screening (to be verified by&#xD;
             test in case of woman of child-bearing potential that do not practice medically&#xD;
             acceptable methods of contraception)&#xD;
&#xD;
         12. Concurrent participation in another clinical trial using any investigational drug or&#xD;
             device.&#xD;
&#xD;
         13. Mental disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanna Levy, Dr</last_name>
    <role>Study Director</role>
    <affiliation>ZygoFix</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanna Levy, Dr</last_name>
    <phone>+972522824966</phone>
    <email>hanna@qsitemed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pecs University Hospital</name>
      <address>
        <city>Pecs</city>
        <zip>H-7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Levy, Dr.</last_name>
      <phone>+972522824966</phone>
      <phone_ext>+972522824966</phone_ext>
      <email>hanna@qsitemed.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <removed_countries>
    <country>Israel</country>
  </removed_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stabilization, facet arthritis, spondylolisthesis, stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

